• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Hanson

Medtronic is actively hiring SNN, SYK, and even re-hiring guys that went to ZB. Why would they buy the dinosaur that is ZB when they can just poach the talent they need? ZB is a sinking ship and the rats are fleeing as fast as they can!
 
































the Bryan hater will. He is at home unemployed
Even management can’t stand BH and our current situation. Who left still thinks he’s doing anything at all? Literally haven’t heard one positive thing about him in months now. In fact, the BH bashing is company wide in every office and it feels like it’s welcomed now. The ass kissers seemed to have figured out that’s not gonna get them anywhere with ZB in this rut.
 




Even management can’t stand BH and our current situation. Who left still thinks he’s doing anything at all? Literally haven’t heard one positive thing about him in months now. In fact, the BH bashing is company wide in every office and it feels like it’s welcomed now. The ass kissers seemed to have figured out that’s not gonna get them anywhere with ZB in this rut.

False. False. False. And you know it. You are hurt still because what happened to YOU.
 
















False. False. False. And you know it. You are hurt still because what happened to YOU.
You have to be delusional to think we're not in bad shape! Analysts are coming out with "strong sell" ratings and there's going to be another round of layoffs early in '22. Place is a mess - and there is zero confidence in leadership. Smart people are looking and leaving.
 




You have to be delusional to think we're not in bad shape! Analysts are coming out with "strong sell" ratings and there's going to be another round of layoffs early in '22. Place is a mess - and there is zero confidence in leadership. Smart people are looking and leaving.
Maybe is not a good idea to work at a pure orthopedic company in the middle of a pandemic. Stryker CEO seems smart.